@misc{indiciaedd53761b28fe,
  title = {FDA panel recommends OTC status for second-generation antihistamines.},
  author = {G Rollins},
  year = {2001},
  doi = {10.1016/s1081-1206(10)62313-7},
  url = {https://pubmed.ncbi.nlm.nih.gov/11476458/},
  note = {Source identifier: 11476458}
}